Recommendations on the use of conjugate pneumococcal vaccine - 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults : economic evidence supplementary appendix.: HP5-154/2023E-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.919396&sl=0
| Department/Agency | Public Health Agency of Canada, issuing body. Canada. National Advisory Committee on Immunization, issuing body. |
|---|---|
| Title | Recommendations on the use of conjugate pneumococcal vaccine - 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults : economic evidence supplementary appendix. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Recommandations sur l'utilisation du vaccin conjugué 15-valent (PNEU-C-15) contre le pneumocoque et 20-valent (PNEU-C-20) contre le pneumocoque chez les adultes : annexe de données économiques supplémentaires. On cover: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI). "Pub.: 220714." Includes bibliographical references (pages 38-44). |
| Publishing information | Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, February 2023. ©2023 |
| Description | 1 online resource (44 pages) : graphs |
| ISBN | 9780660472331 |
| Catalogue number |
|
| Subject terms | Pneumococcal vaccine -- Canada. Vaccines -- Economic aspects -- Canada. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: